Maynard, S. E., Min, J., Merchan, J., Lim, K., Li, J., Mondal, S., . . . Karumanchi, S. A. (2003). Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. American Society for Clinical Investigation.
Chicago Style CitationMaynard, Sharon E., et al. Excess Placental Soluble Fms-like Tyrosine Kinase 1 (sFlt1) May Contribute to Endothelial Dysfunction, Hypertension, and Proteinuria in Preeclampsia. American Society for Clinical Investigation, 2003.
Cita MLAMaynard, Sharon E., et al. Excess Placental Soluble Fms-like Tyrosine Kinase 1 (sFlt1) May Contribute to Endothelial Dysfunction, Hypertension, and Proteinuria in Preeclampsia. American Society for Clinical Investigation, 2003.